Table 3.
Donor–recipient pair | Number of nsSNPGVH | SMM presented peptide-HLA | SMM strongly presented peptide-HLA | NetMHC presented peptide-HLA | NetMHC strongly presented peptide-HLA | Shared presented peptide-HLA |
---|---|---|---|---|---|---|
2 | 4,446 | 1,926 | 250 | 3,883 | 1,376 | 1,332 |
4 | 4,448 | 5,412 | 825 | 3,962 | 885 | 2,441 |
16 | 3,290 | 2,111 | 177 | 1,071 | 427 | 417 |
23 | 3,657 | 13,456 | 705 | 787 | 118 | 534 |
3 | 7,227 | 72,294 | 21,339 | 7,242 | 2,509 | 4,881 |
5 | 6,572 | 30,730 | 2,254 | 2,759 | 538 | 1,865 |
7 | 6,725 | 58,209 | 21,548 | 5,231 | 2,178 | 2,931 |
8 | 6,573 | 65,298 | 19,275 | 4,831 | 2,000 | 2,445 |
10 | 9,203 | 18,396 | 2,283 | 5,002 | 989 | 2,065 |
The number of unique peptide-HLA complexes identified in silico for each donor-recipient pair. Last column represents number of unique peptides predicted to bind the relevant HLA by both algorithms. Unrelated DRP are shaded gray. Presented (intermediate affinity HLA binding) and strongly presented (strong affinity HLA binding) peptide-HLA complexes have IC50 of <500 and <50 nM, respectively.